Yesterday it was reported that the Exec. VP & Chief of Innovation of Cerner Corp (CERN), Jeffrey Townsend, exercised options to sell 349,922 CERN shares at $42.99 a share, for a total transaction value of $23.65M.
In addition to Jeffrey Townsend, 5 other CERN executives reported Sell trades in the last month. Following Jeffrey Townsend’s last CERN Sell transaction on February 15, 2018, the stock climbed by 3.1%.
See today’s analyst top recommended stocks >>
Based on Cerner Corp’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $1.43 billion and quarterly net profit of $127 million. In comparison, last year the company earned revenue of $1.37 billion and had a net profit of $169 million. The company has a one-year high of $76.47 and a one-year low of $48.78. CERN’s market cap is $21.44B and the company has a P/E ratio of 37.21.
In the last 30 days, insiders have sold $29.82M worth of CERN shares and purchased $901.2K worth of CERN shares. The insider sentiment on Cerner Corp has been negative according to 45 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cerner Corp. designs, develops, markets, installs, hosts and supports health care information technology, health care devices, hardware and content solutions for health care organizations and consumers. The company also provides value-added services, including implementation & training, remote hosting, operational management services, revenue cycle services, support and maintenance, health care data analysis, clinical process optimization, transaction processing, employer health centers, employee wellness programs and third party administrator services for employer-based health plans. It operates through the following segments: Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States. The Global segment includes revenue contributions and expenditures linked to business activity in Aruba, Australia, Austria, the Bahamas, Belgium, Bermuda, Brazil, Canada, Cayman Islands, Chile, Denmark, Egypt, England, Finland, France, Germany, Guam, India, Ireland, Kuwait, Luxembourg, Malaysia, Mexico, Netherlands, Norway, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland and the United Arab Emirates. The company was founded by Neal L. Patterson, Clifford W. Illig and Paul N. Gorup in 1979 and is headquartered in North Kansas City, MO.